Dr Adele Hosseini

Experts / Dr Adele Hosseini

Dr Adele Hosseini

Chief Scientific Officer, Bod; Clinical Trial Developer; University Lecturer

Dr. Adele Hosseini has over 18 years’ experience leading the delivery of successful clinical trials including first in human pharmaceuticals and medical devices. Dr. Hosseini has also been involved in many aspects of healthcare including academia such as university lecturing, product development within pharmaceutical, biotech, medical device. She is a pioneer in the Australian medicinal cannabis industry-leading Bod Australia’s Scientific Advisory Board and research program. Over the last three years Dr. Hosseini has developed a deep understanding of medicinal cannabis and continues the strategic direction and development of clinical trials and programs for pharmaceutical cannabis for multiple therapeutic indications.

Reporting medicinal cannabis adverse events to the TGA

Medicinal cannabis is an unregistered medication that is widely prescribed and used

Reporting medicinal cannabis adverse events to the TGA

Medicinal cannabis is an unregistered medication that is widely prescribed and used

By Dr Adele Hosseini